Introduction
A microbead-based assay is one of the most powerful methods for detecting biomolecules in lab-on-a-chip systems due to several outstanding merits.
1,2 First, the surface of the microbeads can be readily modied by various ligands such as aptamers and antibodies to specically capture target biomolecules. Second, the microbead-based assay allows much higher biomolecule capturing efficiency compared to the microchannel based assay, since the surface-to-volume ratio of the microbeads is much larger than that of the microuidic channels. 3 Third, the microbead-based microuidic assay shows efficient mixing of sample solutions by generating torque, whereas the mixing process in conventional microuidic systems depends on the laminar ow which decreases the mobility of the biomolecules. 4 Lastly, the shape and size of the microbeads can be controlled by a batch-type production, leading to uniform loading of ligands to each microbead and subsequent increase in assay reliability. Therefore, microuidic assays with microbeads have attracted much attention in bioanalytical elds.
Recently, various microstructures have been designed to efficiently incorporate microbeads into the microuidic system; physical isolation, 5 magnetic trapping, 6, 7 and electrical trapping. 8 Above all, packing the target-specic microbeads within a specically designed micro structure for physical isolation is the most frequently used strategy due to its simplicity.
9-11
Typically, the microbeads are trapped by a weir or pillars structure in a microuidic channel, resulting in the formation of a loosely packed 3-dimensional (3-D) microbead-bed. The packed structure of the microbeads reduces the diffusion length of sample solution, which is favorable to capture target biomolecules via specic reaction with ligands on the surface of microbeads. Therefore, microuidic assay with 3-D microbeadbed has been successfully applied for highly sensitive detection of various biomolecules such as DNA, 12 viruses, 13 and cancer biomarkers. 14 The detection of target-molecule binding event in a microuidic system mainly relies on the use of uorescent dye or nanoparticle (NP) probe. 6, 15 Especially, uorescent NPs containing target biomolecules have been broadly employed as a secondary probe, and their uorescence signals were directly measured in the microbead-bed region aer their binding to the microbead. However, these direct measurements in the microbead-bed region have been suffered from several critical problems: rst, inaccuracy of the uorescent signal measurement is unavoidable due to the depth of 3-D structured microbead-bead. 16 As the optical signals generated from the NP probes are distorted and scattered when the signals are passed through the microbead-bed, they exhibit distance variations when viewed by uorescent microscopy. Hence, an expensive and complex instrument such as a confocal microscope is necessary to measure the optical signals of NPs accurately in the microbead-bed region. Second, the area of the microbeadbed is usually too large to measure the optical signals. A large amount of the microbeads is required for the sensitive detection of biomolecules, which inevitably give rise to long measuring time due to the increase in the amount of the microbeads and subsequent measuring area. 17 Third, the microbeads usually emit its own uorescent signals which can interfere the sensitive detection of NPs uorescent signal with decreased signal-to-noise ratio (SNR).
18 Therefore, a new measuring method which is not inuenced by the structure and background signal of the 3-D microbead-bed is highly required for sensitive and quantitative detection of biomolecules.
Previously, we have developed a nanoslit membrane structure for size-dependent particle trapping, 19 which enabled particle separation, concentration, and quantication. Herein, we demonstrate a new assay strategy based on the nanoslitconcentration-chip (NC-chip) integrated microbead assay system for the sensitive and quantitative detection of target biomolecules. Microbeads were trapped in a weir-structured microbead-trapping-chip (MT-chip) to form 3-D packed microbead-bed, and effective binding event occurs between microbeads and NPs based on ligand-target molecules interactions. Aer the binding, the specically bound NPs were released from the microbeads, and transported to the NC-chip, where NPs could give highly enhanced uorescent signals as a result of concentrated NPs within small measuring area. Thus, the NC-chip integrated microbead assay system was successfully applied to streptavidin assay with increased detection sensitivity compared to the conventional microbead based assay systems.
Design and fabrication
Design of NC-chip integrated microbead assay system
The NC-chip integrated microbead assay system is comprised of two separated devices; the MT-chip for efficient recognition events between target biomolecules adsorbed on NPs and target-specic ligand on microbeads, and the NC-chip for sensitive and quantitative detection of target bound NP probes. As shown in Fig. 1 , each part was designed to have a characteristic structure corresponding to each function. In the MTchip, a weir structure (500 mm width, 80 mm and 20 mm height) was employed to conne 30 mm-sized TentaGel microbeads bearing a peptide ligand for specic reaction with streptavidin coated uorescent NPs (Stav-FNPs). Stav-FNPs were released from the microbeads and collected in the NCchip aer the binding events in the MT-chip. The NC-chip is equipped with a nanoslit membrane to concentrate Stav-FNPs in a small detection area (500 mm Â 300 mm) for sensitive protein detection. 
Fabrication process and results of NC-chip integrated microbead assay system
The detailed fabrication process of the MT-and NC-chips are shown in Fig. 2 . For fabrication of the MT-chip, the weirstructured microuidic PDMS mold was prepared by deep reactive ion etching (DRIE) and SU-8 photolithography (Fig. 2a) . The rst layer of the microuidic channel was fabricated by etching 20 mm via DRIE. SU-8 photoresist was then patterned on the microuidic channel at a height of 60 mm to make a weir structure. A PDMS uid channel was replicated from the mold and bonded to a slide glass using O 2 plasma surface treatment. Fig. 2b shows the NC-chip fabrication process. First, a Si 3 N 4 layer (1 mm) was deposited on a silicon wafer by low-pressure chemical vapor deposition (LPCVD) to form a membrane structure. A 500 nm Â 4 mm slit pattern array was patterned on the Si 3 N 4 layer by stepper lithography and a dry etching process. The silicon substrate located under the nanoslit-patterned Si 3 N 4 membrane was then removed by 4 mm DRIE and potassium hydroxide (KOH) wet etching for 30 minutes. The wet etching process released the nanoslit-patterned Si 3 N 4 membrane and formed a cavity for bottom uid channels. Finally, Cr/Au was deposited on the released nanoslit membrane by sputtering to narrow the width of the nanoslit from 500 nm to 250 nm. This additional sputtering process proves to be simple to adjust the width of the nanoslit pattern efficiently, and can be applied to further decrease the width. The PDMS channels of NC-chip was also fabricated using a SU-8 mold. Finally, the PDMS channel and the nanoslit-membrane were clamped by an acrylic plastic housing for sample uid injection without leakage.
The fabrication results of the MT-chip and the NC-chip are shown in Fig. 2c and d . The channel height of MT-chip abruptly decreased from 80 mm to 20 mm at the end of the channel, resulting in the weir-structured channel (Fig. 2c) . As the diameter of microbead is 30 mm, this weir structure of MT-chip was sufficient to trap 30 mm-sized microbeads in the 80 mm height zone. Fig. 2d shows the Cr/Au deposited nanoslit membrane and the aligned PDMS channel. The PDMS channel was aligned to guide ow of the sample solution into the membrane. In addition, the enlarged SEM images show that the NC-chip consisted of numerous nanoslit array, in which NPs larger than the slit width could be trapped efficiently as shown in Fig. 4d (more fabrication results and SEM images are shown in Fig. S1 ESI †).
Experimental set up for NC-chip integrated microbead assay system
A pressure-based uidic control system was employed for precise sample transportation, mixing, and washing, instead of using a microsyringe pump. Compared to the microsyringe pump, a pressure-driven ow has advantages of a fast response time and small ow uctuations. The schematics of the experimental set-up is illustrated in Fig. 3 . The sample solutions were loaded in a plastic disposable vial (reservoir #1) and connected to the inlet of the MT-chip for a forward ow. The outlet of the MT-chip was also connected to another plastic disposable vial (reservoir #2) for a backward ow. Forward/backward ows were controlled via solenoid valves with a Labview™ program. The sequential forward/backward ows enable effective mixing of the NPs with the microbeads, leading to effective target binding. Aer the binding events, only forward ow was allowed for washing, and waste was eluted via an outlet to reservoir #2. For detection, the outlet of the MT-chip was connected to the inlet of the NC-chip with a valve to allow the target bound NPs to ow. All events occurring in the MT-and NC-chips were monitored using a CCD camera-linked microscope (ProgRes C3, JENOPTIK, Germany), and the trapped NPs were also quantied by uorescence signals using a uorescence lter set (467-498 nm excitation wavelength, 520 nm emission wavelength).
Result and discussion
Experimental design to evaluate the performance of the NCchip integrated microbead assay system
To demonstrate the efficiency of the proposed system, streptavidin and HPQ containing pentapeptide 20 was chosen as a model protein-ligand binding assay. As it has been known that the affinity of the HPQ-containing peptide is depending on the peptide sequence, accuracy of the proposed assay system could be evaluated. We chose three pentapeptides (LHPQF, FHPQG, and IHPQG), which has high, middle, and low affinities to streptavidin. Each pentapeptide was synthesized on TentaGel bead (TG-peptide) by the conventional solid-phase synthesis method. Commercial streptavidin-coated uorescent NPs (StavFNPs, SVFP-0552-5, Spherotech, USA) were used as the target material with a signaling probe. The assay performance of the proposed system was evaluated in two ways. First, the efficiency of NPs trapping in the NC-chip was investigated to nd out the detection limit improvements. Next, the accuracy of the assay system was investigated using the LHPQF, FHPQG, and IHPQG conjugated TentaGel beads. The assay results for the three pentapeptides were compared to their known affinities toward streptavidin.
Assay results of the NC-chip integrated microbead assay systems
The assay procedure was illustrated in Fig. 4a. (i) First, TGpeptide were trapped in a weir-structure of the MT-chip within 5 min aer injection (z2 Â 10 3 ).
(ii) Stav-FNPs were injected to the TG-peptide packed column, followed by mixing with pressure-based bi-directional ows for 30 min. The forward and backward ows were applied for 2.8 s and 1.2 s at 1.5 kPa for one period and repeated several times. (iii) Aer the incubation step, the unbounded Stav-FNPs in the MT-chip was washed out by bi-directional ow with a PBS solution (10 mM, pH 7.0) for 10 min. (iv) Next, the captured Stav-FNPs were released from the microbeads by means of chemical and physical treatment. Chemical release of FNPs from TG-peptide was conducted using formamide which can induce dissociation of the streptavidin-peptide binding by conformational change of streptavidin. 21 In addition, we found out the additional pressure-based releasing step was essential to release the Stav-FNPs which wasn't released in the rst chemical treatment (Fig. S2 †) . Therefore, a high pressure bi-directional ow was applied to the microbeads to give a vibrational shock to ensure improved releasing of FNPs. The applied pressure was 15 kPa and the duration time of forward/backward ow was 0.55/0.45 s for one cycle period. (v) Finally, a 30 ml of the solution which contained the released FNPs was transported to the NC-chip and injected into the nanoslit membrane for 3 min with 5 kPa. The uorescence signal of trapped FNPs were detected and quantied using uorescence microscopy.
Each assay steps described above was conrmed by uores-cence measurement. (i) TG-peptide (LHPQF) packed in the MTchip emitted weak uorescence signal due to the innate background of the resin beads, which could be considered as a noise leading to decrease in signal sensitivity. (ii) Bi-directional ow depending on the pressure-driven mixing demonstrated that Stav-FNPs (20 ml, 10 8 ml À1 ) were reacted well with the pre- ESI †). The target FNP recognition in the microbead column, the FNP release from the microbeads, and the FNP trapping and detection in the NC-chip were successfully observed using the uorescent microscopy. These results clearly demonstrate the basic concept and working principle of the NC-chip integrated microbead assay system.
Enhancement of the detection sensitivity using NC-chip integrated microbead assay system
The NC-chip integrated microbead assay system is expected to enhance the detection sensitivity of target NP probes by concentrating the NP probes within the small detection area of NC-chip. Conventional microbead assay usually utilizes large size three-dimensional microbead column to maximize the binding efficiency between the target molecules and the ligand conjugated microbeads. However, this can also decrease the population density of the target NP probes leading to low sensitivity, especially at low target concentrations. We investigated the enrichment effect of the Stav-FNPs via trapping within the NC-chip on the assay sensitivity. For this, Stav-FNPs of various concentrations (1.25 Â 10 6 ml À1 , 2.5 Â 10 6 ml À1 , 5 Â 10 6 ml À1 , and 10 7 ml À1 ) were injected and incubated with the packed TG-peptide in the MT-chip. Aer incubation and washing, the uorescent signals of the bound Stav-FNPs in the MT-chip were measured for each Stav-FNPs concentrations. Then, the captured Stav-FNPs were released from the TGpeptide in the MT-chip and transported to the NC-chip. Finally, the uorescent signals from Stav-FNPs trapped on the nanoslit membrane were measured. As shown in Fig. 5a , the uorescence signals from the FNPs were signicantly higher in the NC-chip compared to the signals from the MT-chip. Signals from the NC-chip were homogeneous and strong over the whole detection area, while irregular and overlapped weak uorescence signals were observed from the microbead-bed in the MT-chip. For more rigorous comparison on the detection sensitivity, uorescent signals of each image were quantied and normalized using an image analysis so-ware (NI Vision Assistant). As shown in Fig. 5b , the uorescence signal of FNPs in the NC-chip increased proportionally with Stav-FNPs concentrations ranging from 1.25 Â 10 6 to 10 7 ml À1 .
Whereas, the uorescence signal of FNPs in the MT-chip showed marginal increase up to the concentration of 10 7 ml
À1
Stav-FNPs that showed similar detection limit of conventional peptide-streptavidin microbead assay (Fig. S3 †) . This increased sensitivity of NC-chip might be attributed to the concentration of Stav-FNPs at the nanoslit membrane. The nanoslit membrane has 500 mm Â 300 mm area which is 13.3 times smaller than the area of the microbead-bed in the MT-chip (500 mm Â $4000 mm). The low background noise of the nanoslit membrane also contributes to an increase in detection sensitivity. As nanoslit membrane (Cr/Au deposited) emit signi-cantly low background uorescence signal compared to the polymer microbeads, the contrast of the uorescence of FNPs could be enhanced. The detection limit of FNPs in the NC-chip was expected to be lower than 1.25 Â 10 6 Stav-FNPs ml
because the normalized uorescent signal was substantially high (2.2) at 1.25 Â 10 6 Stav-FNPs ml À1 , whereas uorescence signal in MT-chip showed only small signal difference (1.3) even at higher FNP concentrations (10 7 ml À1 ). The detection limit of NC-chip integrated system for the detection of streptavidin was 163 pM, which is lower than the previously reported chip-based biotin-streptavidin assay. 22, 23 Considering that HPQ peptides are known to exhibit lower affinity to streptavidin than biotin, 20, 24, 25 these results clearly suggest that the NC-chip based detection can signicantly enhance the detection sensitivity by concentrating the target Stav-FNPs into a small nanoslit membrane region. The detection sensitivity can be further increased by simply increasing the number of packed microbeads in MT-chip. Furthermore, the NC-chip based detection system is very useful because it can be widely utilized in the microbead-based assay system by simply connecting the NC-chip to the microbead column.
Quantitative analysis of the streptavidin-pentapeptide binding using the NC-chip integrated microbead assay system Generally, uorescence signals from the microbead column are hard to quantify with high accuracy because the background uorescent signals emitted from the microbeads exhibit wide variety due to the size, packing density, and the surface properties of the microbeads. However, the NC-chip integrated microbead assay system can remove the background uores-cent signals emitted from the microbeads, and only measure the signals of the FNPs trapped within the nanoslit membrane which emits low background uorescent signal. Therefore, compared to the conventional microbead assay system, the proposed assay system could have higher detection accuracy and reliability for the quantitative analysis. To investigate the ability of the quantitative analysis of the NC-chip based detection, streptavidin-peptide binding assay was performed using three different HPQ containing pentapeptides, LHPQF, FHPQG, and IHPQG, which have high, middle, and low affinities to streptavidin. It is expected that uorescence intensity from the trapped Stav-FNPs in NC-chip reveals the same order of the affinity of HPQ peptides to streptavidin. The experimental procedures were the same as previously described and the concentration of the Stav-FNPs were 10 7 ml
. Fig. 6a showed the experimental results of the streptavidin-peptide binding assay using the peptides. The uorescent signals from the microbead column were very small and irregular, and not matched to the expected assay results. However, the uorescent signals at the NC-chip were clearly matched to the expected values (LHPQF > FHPQG > IHPQH). The uorescent signals were also quantied by the image analysis soware (NI Vision Assistant) as shown in Fig. 6b , which showed dramatic difference in the detection accuracy and reliability between the MTchip and the NC-chip. In the MT-chip, the signals of the FNPs were overlapped and buried under the variation of background signals so that affinity tendency cannot be observed. On the other hand, the NC-chip clearly showed the same affinity tendency as expected. From these results, we can conclude that the NC-chip integrated microbead assay system improved the detection accuracy and reliability by reducing the variation of the background uorescent signals that is an inevitable problem when the microbead is used for bioassay. Moreover, the assay results of the proposed system are highly quantitative, and thus the NC-chip device can be applied to various proteinligand affinity screening.
Conclusion
We demonstrated that the NC-chip integrated microbead assay system could improve the detection sensitivity and signal reliability of the microbead based assay system. The assay system consists of the bio-molecule capturing device (MT-chip) and the signal amplication and detection device (NC-chip) to improve the detection limit with quantication ability. In particular, the nanoslit membrane of the NC-chip can concentrate NPs into a small area, and thus, enhance its uorescence intensity as well as detection sensitivity. In addition, trapping the FNPs released from the microbead in the NC-chip can contribute to more accurate and reliable bioassay with high SNR of the FNPs as the background signal of nanoslit membrane is substantially low compared to that of microbead. The excellent performance of the NC-chip system was successfully demonstrated via streptavidin-peptide binding assay as a model. The NC-chip integrated microbead assay system showed the improved detection sensitivity over 10 times compared to that of the conventional microbead based assay. This NC-chip integrated microbead assay system has a great potential for the sensitive and quantitative detection of various target molecules in various bio related elds.
